|
| Press Releases |
|
 |
|
| Tuesday, June 11, 2024 |
|
|
Dynasty's Brandy Wins First Gold Award at 2024 IWSC |
| Dynasty Fine Wines Group Limited ("Dynasty" or "Group") (stock code: 00828), a premier winemaker in China, announced that its "Dynasty Jin.Y Brandy XO Barrel-Aged 18 Years" won the Gold Award at the 2024 International Wine and Spirit Competition (IWSC) for the first time, and its "Golden Dynasty Dry Red Wine" also won the Bronze Award at the competition. more info >> |
|
| Thursday, March 28, 2024 |
|
|
王朝酒业公布2023年全年业绩 |
| more info >> |
|
|
王朝酒業公佈2023年全年業績 |
| more info >> |
|
|
Dynasty Fine Wines Announces 2023 Annual Results |
| Dynasty Fine Wines Group Limited ("Dynasty" or "the Group") (Stock Code: 00828), a premier grape winemaker in China, today announced its audited annual results for the year ended 31 December 2023 ("the Year"). more info >> |
|
| Tuesday, August 29, 2023 |
|
|
王朝酒业2023年上半年收入增长27%至1.282亿港元 |
| 中国优质葡萄酒生产商王朝酒业集团有限公司（「王朝」或「集团」）（股份代号：00828）今日公布截至2023年6月30日止未经审核之中期业绩。 more info >> |
|
|
王朝酒業2023年上半年收入增長27%至1.282億港元 |
| 中國優質葡萄酒生產商王朝酒業集團有限公司（「王朝」或「集團」）（股份代號：00828）今日公佈截至2023年6月30日止未經審核之中期業績。 more info >> |
|
|
Dynasty Fine Wines Revenue for 2023 1H Increases by 27% to HKD$128.2 Million |
Dynasty Fine Wines Group Limited ("Dynasty" or the "Group") (Stock Code: 00828), a premier grape winemaker in China, today announced its unaudited interim results for the six months ended 30 June 2023.
more info >> |
|
| Monday, June 12, 2023 |
|
|
王朝酒业2023年新产品年华系列以满足不同消费群体需求 |
| 中国优质葡萄酒生产商王朝酒业集团有限公司(「王朝」或「集团」)(股份代号：00828) 于2023年推进新产品上市，推出王朝年华系列，将通过更好的商业模式，保障渠道利润和消费者对美酒的需求。 more info >> |
|
|
王朝酒業2023年新產品年華系列以滿足不同消費群體需求 |
| 中國優質葡萄酒生產商王朝酒業集團有限公司(「王朝」或「集團」)(股份代號：00828) 於2023年推進新產品上市，推出王朝年華系列，將通過更好的商業模式，保障渠道利潤和消費者對美酒的需求。 more info >> |
|
|
Dynasty Launches New NIANHUA Series in 2023 to Meet Needs of Different Consumer Groups |
| Dynasty Fine Wines Group Limited ("Dynasty" or "the Group") (Stock Code: 00828), a premier winemaker in China, has kept launching new products in 2023 including the NIANHUA series and, via an improved business model, is safeguarding channel profit while also meeting consumers' demand for fine wines. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
周大福人壽支持《財政預算案》有關跨境安老、落實《香港可持續披露準則》以及推動體育普及化、盛事化等措施
Feb 25, 2026 18:07 HKT/SGT
|
|
|
HKTDC welcomes the 2026-27 Budget
Feb 25, 2026 17:29 HKT/SGT
|
|
|
維昇藥業（2561.HK）維臻高(R)獲批：重長效生長激素王者登場 重構百億市場的商業天花板
Feb 25, 2026 14:58 HKT/SGT
|
|
|
Shoucheng Holdings (00697.HK) Sees Long-Term International Capital Rotation as Robotics Portfolio Enters Harvest Phase
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎來國際長線接盤 機器人產業生態進入價值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
首程控股（00697.HK）迎来国际长线接盘 机器人产业生态进入价值收割期
Feb 25, 2026 12:23 HKT/SGT
|
|
|
ベイシアのスーパーマーケット内の冷蔵・冷凍庫の温度点検・記録業務を富士通のIoT可視化ソリューションにより自動化
Feb 25, 2026 12:00: JST
|
|
|
Beisia Automates Supermarket Refrigerator Temperature Monitoring and Recording with Fujitsu's IoT Visualization Solution
Feb 25, 2026 12:00 JST
|
|
|
國泰君安國際獲批使用SIMM 衍生品風險管理接軌國際標準
Feb 25, 2026 10:34 HKT/SGT
|
|
|
国泰君安国际获批使用SIMM 衍生品风险管理接轨国际标准
Feb 25, 2026 10:34 HKT/SGT
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 22:30: JST
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT/SGT
|
|
|
TANAKA to Provide Medals for the Tokyo Marathon 2026 That Represent All the Participants in the Event with Woven Lines
Feb 24, 2026 22:00 JST
|
|
|
康哲藥業（867.HK/8A8.SG）：創新藥磷酸蘆可替尼乳膏增加特應性皮炎（AD）適應症中國上市許可申請獲受理並獲納入優先審評
Feb 24, 2026 20:31 HKT/SGT
|
|
|
康哲药业（867.HK/8A8.SG）：创新药磷酸芦可替尼乳膏增加特应性皮炎（AD）适应症中国上市许可申请获受理并获纳入优先审评
Feb 24, 2026 20:19 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
